SBIR Phase I: Development of a Microfluidic Device for Rapid Analysis, Sorting, and Collection of Biological Particles using Photonic Forces

Information

  • NSF Award
  • 0320418
Owner
  • Award Id
    0320418
  • Award Effective Date
    7/1/2003 - 21 years ago
  • Award Expiration Date
    12/31/2003 - 21 years ago
  • Award Amount
    $ 99,771.00
  • Award Instrument
    Standard Grant

SBIR Phase I: Development of a Microfluidic Device for Rapid Analysis, Sorting, and Collection of Biological Particles using Photonic Forces

This Small Business Innovation Research (SBIR) Phase I project propses to demonstrate that moving optical gradient forces, Optophoresis, provide selective and sensitive analysis and sorting of cells important to optimizing bioreactor production processes. Isolation of stable cell populations, as related to functional phenotype, and maximizing viable cell density are critical to the efficient and economic production of protein-based therapeutic agents. The ability to remove pro-apoptotic cells will significantly improve bioprocess technology. This Phase I effort will demonstrate the analysis, sorting, and recovery of non-apoptotic cells for further manipulations, and the isolation of cells with certain biological characteristics, for example secretion levels. In a microsorter device, cells will be simultaneously analyzed and sorted by the optical gradient force based on the native cell characteristics (such as size, morphology, dielectric properties etc.). The objectives of the Phase I project are : 1) to build an optical and microfluidics workstation; 2) to fabricate microfluidic devices for aseptic loading and recovery of cells, 3) to identify and characterize apoptotic and secretor cell models, 4) to demonstrate that Optophoresis can discriminate between different cell subpopulations, and 5) to collect sorted populations for further manipulations. In the follow on Phase II project, the microsorter instrument will be further developed for both research and continuous on-line monitoring needs.<br/><br/>The commercial applications of this project include bioprocess engineering, clinical diagnostics, cancer testing, environmental monitoring, tissue engineering, and drug discovery.

  • Program Officer
    Om P. Sahai
  • Min Amd Letter Date
    6/12/2003 - 21 years ago
  • Max Amd Letter Date
    10/23/2003 - 21 years ago
  • ARRA Amount

Institutions

  • Name
    GENOPTIX INC
  • City
    SAN DIEGO
  • State
    CA
  • Country
    United States
  • Address
    3398 CARMEL MTN RD
  • Postal Code
    921211044
  • Phone Number
    8585235003

Investigators

  • First Name
    Catherine
  • Last Name
    Schnabel
  • Email Address
    cschnabel@genoptix.com
  • Start Date
    6/12/2003 12:00:00 AM
  • End Date
    10/23/2003
  • First Name
    Jonathan
  • Last Name
    Diver
  • Email Address
    jdiver@genoptix.com
  • Start Date
    10/23/2003 12:00:00 AM

FOA Information

  • Name
    Industrial Technology
  • Code
    308000